Navigation Links
Healthcare VC Dr. Dinesh Patel to serve on Tute Genomics Board of Directors
Date:11/5/2013

SALT LAKE CITY, Nov. 5, 2013 /PRNewswire-iReach/ -- Dinesh Patel, PhD, co-founder of vSpring Capital (now Signal Peak Ventures), has joined the board of directors for Utah-based Tute Genomics, founded in 2012.  Tute is a professional grade, cloud-based application for the rapid and cost-effective analysis of entire human genomes for healthcare & biomedical research. Tute Genomics comes at a time when the current pace of interpretation of genomic data cannot keep up with the increasing volume of big data that is flooding hospitals & research institutions, calling for a system to analyze these data fast enough to infer the biological insights needed to stay ahead and guide decision-making.   This is the nature of Tute's business and is aligned well with Dr. Patel's knowledge base and skill set.

(Photo:  http://photos.prnewswire.com/prnh/20131105/MN10545)

Dr. Patel brings with him decades of experience which, combined with his belief in the mission of Tute Genomics, are sure to provide a great advantage to the growing company.  Dr. Patel has had leading roles at several life sciences companies. From 1985 to 1999, Dr. Patel served as Co-Founder, Chairman of the Board of Directors and President of TheraTech, Inc., a biotechnology company which he took public and eventually sold  for $350 million to Watson Pharmaceuticals. From 1999 to 2004 he was the Founder, Chairman, and President of Ashni Naturaceuticals, Inc., a company that specializes in the research, development and marketing of clinically tested and patent-protected nutraceutical products. Prior to Signal Peak Ventures, Dr. Patel was an active angel investor in over 20 biotech and technology companies.

Dr. Patel also served on the board of Mediconnect Global, a worldwide leader in medical record retrieval, digitization, and one of the largest cloud-based health information exchanges. In March 2012, Mediconnect was acquired by Verisk Analytics (VRSK) for over $377 million.

Dr. Patel serves on several non-profit boards, and has won numerous awards including; 2010 Utah Youth Village Helping Hand Award, 2009 Utah Genius Lifetime Achievement Award, 2006 Utah Technology Council Hall of Fame Inductee, 2006 Ellis Island Medal of Honor, US Small Business Administration's Business Achiever Award, Scientific and Technology Award (State of Utah), Entrepreneur of the Year Award (Mountain West Venture Group) and Scientific and Technology Development Pioneer of Progress Award to name a few. He is also a charter member of The Indus Entrepreneurs (TiE).

Dr. Patel has also served as co-chair of Governor Huntsman's transition and he is the Chairman of the USTAR Governing Authority board.  He is a member of the Life Sciences and Management Board at the University of Pennsylvania and on the National Advisory Board for the University of Michigan's Technology Transfer Office.

Of his new role with Tute, Dr. Patel is excited to be a part of this promising company and states "Tute Genomics provides a unique and valuable solution to analyzing and understanding the human genome, and will play an important role in advancing personalized medicine."

About Tute Genomics:

Tute Genomics is a cloud-based clinical genome interpretation engine that is secure, robust, professional grade, and has the ability to analyze and annotate personal genomes in a rapid and cost-effective way.  Whole genome sequencing is transforming research & medicine. Researchers and laboratories are getting flooded with high-throughput genetics data sets, but the ability to infer biological insights and guide decision making lag behind significantly. There is an urgent need for tools to analyze genetic variants from personal genomes in research and in clinical settings. Tute Genomics is solving this problem with a web-based clinical genome interpretation engine.  To learn more about Tute Genomics, please go to www.tutegenomics.com

About Dinesh Patel:

Born and raised in Zambia, Africa, Dr. Patel received his bachelor's degree in Pharmacy at Gujarat University located in Ahmedabad, Gujarat, India.  He earned his master's degree from the Philadelphia College of Pharmacy and his Ph.D. in Physical Pharmacy from the University of Michigan. Dr. Patel led the firm's investments in Altea Therapeutics, Axial, Exagen, Inflabloc, Protolex, Q Therapeutics, Zars and Salus Therapeutics which was acquired by Genta (NASDAQ: GNTA) for $30 million.

Media Contact: Lynn Dakoulas, Tute Genomics, 8017104035, lynn@tutegenomics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Tute Genomics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
6. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
7. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
8. ViroPharma to Participate in Two December Healthcare Investor Conferences
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
11. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... NEW YORK , February 4, 2016 ... (OTCQB: QBIO), a biotechnology acceleration company is pleased to provide ... --> --> Over the last 3 months ... note and securities purchase agreements exceeding $1,000,000. As a result, ... under our Mannin Research Inc. license agreement and expect that ...
(Date:2/4/2016)... England , February 4, 2016 ... Bioscience Laboratories (ABL), Inc. --> Strasbourg, France ... Inc. --> PharmaVentures is pleased to announce that ... of its biopharmaceutical manufacturing unit in Strasbourg, France ... Inc. --> --> Transgene ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma ... company that applies its innovative TransCon technology to address ... at an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare ... Date:  , Wednesday, February 10, 2016 Time:  , ... www.ascendispharma.com . --> An audio webcast of ...
(Date:2/3/2016)... ... 03, 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ) ... addition of a powerful “Session Preview” feature to its FastX remote Linux visualization ... remote Linux desktop or other applications (sessions) they have running on a remote ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/27/2016)...  Rite Track, Inc. a leading semiconductor equipment and ... Ohio announced today the acquisition of PLUS LLC. ... Austin, Texas , will significantly bolster ... installations and technical support offerings for TEL Track Systems. ... "PLUS has provided world class service including refurbishment, enhancements ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):